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ABSTRAK
Sebelum program rehabilitasi senaman dipreskripsikan untuk pesakit strok, 
kapasiti kardiopulmonari perlu dinilai dengan tepat untuk menentukan senaman 
intolerans dan intensiti latihan yang diperlukan. Walau bagaimanapun, belum 
ada ujian senaman kardiopulmonari (CPET) yang sesuai untuk pesakit strok. Ini 
adalah disebabkan oleh ketidakupayaan fizikal yang dialami oleh mereka. Justeru, 
tujuan kajian ini adalah membangunkan protokol ujian senaman kardiopulmonari 
yang menggunakan protokol rowing-ramp, serta menentukan kesahan serta 
kebolehpercayaan protokol ujian tersebut. Sebelas orang pesakit strok (6 lelaki; 
5 wanita; umur, 45 + 16.01 tahun} melakukan dua ujian senaman ansur maju 
menggunakan ergometer rowing (Concept II) bagi menentukan penggunaan 
oksigen puncak (VO2 puncak). Kebolehpercayaan uji-ulang uji untuk VO2 
puncak, diukur berselang 1 minggu dan memberikan nilai pekali korelasi intra-
kelas masing-masing 0.97 dan 0.95. Persamaan regresi linear dibangunkan untuk 
menentukan nilai VO2 puncak berdasarkan kepada kuasa kayuhan pada tahap 
tertinggi. Kesahan dan kebolehpercayaan persamaan juga dihasilkan. Persamaan 
regresi yang diperolehi ialah VO2 puncak=11.429 +±0.232 (Kuasa Kayuhan Tahap 
Tertinggi) + 12.63 (F=25.326, p<0.01; R=0.859, R2=0.738). Had persetujuan antara 
VO2 puncak yang diukur dan anggaran boleh diterima, dengan purata bias 0.37 
ml/kg/min. Pekali kesahan (R) adalah 0.83 (p<0.01) dan 0.81 (p<0.01) dalam 
kedua-dua percubaan. Pekali kebolehpercayaan uji-ulang uji untuk VO2 puncak 
anggaran adalah 0.95 (p<0.01). Hubungan positif antara kuasa kayuhan tahap 
tertinggi dan VO2 puncak mencadangkan bahawa protokol Rowing-Ramp ini boleh 
digunakan untuk mengukur VO2 puncak pesakit strok. Kajian lanjut diperlukan 
demi pengesahan bersilang persamaan regresi menggunakan saiz sampel yang 
lebih besar, dengan mengambil kira jenis strok dan tahap keparahan.
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Kata kunci:  penggunaan oksigen, protokol CPET, rowing, strok hemiparetik, ujian 
senaman kardiopulmonari
ABSTRACT 
Cardiopulmonary capacity should be evaluated accurately to determine exercise 
intolerance and training intensity of stroke survivors before an exercise rehabilitation 
programme is prescribed. However, no cardiopulmonary exercise test (CPET) is 
suitable because of the stroke victims’ physical impairment. The aim of this study 
was to develop and validate a new rowing-ramp protocol as a CPET for stroke 
survivors. Eleven stroke patients (6 male; 5 female; age, 45 + 16.01 years, performed 
two incremental exercise tests on a Concept II rowing ergometer to determine the 
peak oxygen consumption (VO2 peak). Test-retest reliability for VO2 peak, measured 
1-week apart, resulted in an intra-class correlation of 0.97 and 0.95, respectively. A 
linear regression equation was developed to predict the VO2 peak from final stage 
stroke power. Validity and reliability of the prediction equation were established. 
The regression equation for predicted VO2 peak was VO2 peak=11.429±+ 0.232 
(Final Stage Stroke Power) + 12.63 (F=25.326, p<0.01; R=0.859, R2=0.738). Limits 
of agreement between predicted and measured VO2 peak were acceptable, with 
a mean bias of 0.37 ml/kg/min. The validity coefficient (R) was 0.83 (p<0.01) and 
0.81 (p<0.01) in both trials. Test-Retest reliability coefficient for predicted VO2 peak 
0.95 (p<0.01). The positive relationship between Final Stage Stroke Power and VO2 
peak suggests that the Rowing-Ramp protocol could be used to measure VO2 peak 
of stroke survivors. Additional studies are needed to cross-validate the regression 
equation using larger sample size, different type and severity of stroke.
Keywords: cardiopulmonary exercise test, oxygen consumption, rowing, CPET 
protocol, stroke hemiparetic 
rest or immobility leads to a reduction 
of oxidative capacity of the paretic 
muscles (Hastings et al. 2012) and 
decreased motor unit recruitment, 
which would lead to reduced central 
endurance (Hamzat & Alabi 2006; 
Stoller et al. 2012). Studies have shown 
that after a stroke attack, patients 
have poor cardiovascular endurance 
(Stoller et al. 2012; Billinger et al. 
2015). Therefore, determining exercise 
capacity and exercise intolerance 
INTRODUCTION
Stroke, including hemiparetic stroke, 
has been recognised as a cause of 
physical disability leading to immobility 
and reduction in activities of daily living 
(Fujita et al. 2015; Hyndman & Ashburn 
2003). Furthermore, long term and a 
new approach to the rehabilitation 
of stroke patients in Malaysia were 
needed (Aziz & Raymond 2008). After 
an extended period of inactivity, bed 
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of stroke survivors are important 
as a safety measure, as well as for 
prescribing an optimal exercise 
rehabilitation programme.
 The cardiopulmonary exercise test 
(CPET) is most often recommended 
to assess the exercise capacity 
(Saengsuwan et al. 2015), including 
diagnosis of cardiovascular problems, 
and to determine individualised 
training intensity. CPET has been 
used to measure a person’s maximum 
oxygen uptake (VO2 max), maximal 
oxygen uptake (VO2 peak), ventilatory 
threshold, and peak heart rate (HR 
peak) to set an optimum target 
intensity for an individual (Marzolini 
et al. 2016). CPET was widely used 
as a predictor of functional status and 
impairments (Albouaini et al. 2007). 
Often, standardised protocols such as 
the Bruce protocol, are widely applied 
in both health and clinical settings 
(Balady et al. 2010; Ratter et al. 2014; 
Ratter et al. 2003).  However, because 
there is a high workload increment 
required at each stage, which is not 
possible for people with physical 
impairments, a ramp protocol had 
been substituted because of its small 
workload increment and shorter 
duration at each stage (Sobral 2003; 
Myers & Froelicher 1990). 
 Besides the duration of the stage, 
exercise mode also plays an important 
role in predicting the VO2 peak. 
Since, hemiparetic stroke patients 
have physical impairment especially 
poor posture control, poor static and 
dynamic balance, and even most of 
them having difficulties in maintaining 
sitting balance or standing, taking a 
step, walking, lifting arm, raising a 
hand, hand grip, and keep heads up. 
With the features of a rowing machine, 
which include secure foot placement, 
rowing handles, and a mobile seat, 
allows a patient to stabilise and 
perform the rowing movement safely. 
 Most of the rowing CPET protocol 
are using HR as a marker (Huntsman et 
al. 2010; Martins et al. 2012). However, 
HR is not a reliable marker to predict 
VO2 max in stroke patients because 
they often take medications such as 
beta-blockers (Albouaini et al. 2007). 
Even, the ventilatory threshold is also 
influenced by beta-blockers and also 
can not be used as a cardiopulmonary 
performance measure (Wallen et al., 
2017). 
 Therefore, a work rate is more 
suitable marker in estimating the 
cardiopulmonary capacity of stroke 
patients. There are few rowing-specific 
tests that were developed to predict 
VO2 max using the work rate. Such as 
stroke rate (Lakomy & Lakomy 1993), 
critical velocity (Kendall et al. 2012), 
and power output (Kendall et al. 2012; 
Klusiewicz et al. 2016). However, 
these protocols were developed for 
non-clinical population, using step 
incremental protocol with a longer 
working duration and big workload 
increment. Which is not suitable 
for stroke patients because of their 
physical impairment and limitations. 
Therefore, this study aimed to develop 
a rowing CPET protocol specifically 
for hemiparetic stroke patients, using a 
ramp protocol with a shorter duration 
at each stage and smaller workload 
increments. Which are power output 
per stroke (Watt) and a number of 
strokes per minute, stroke rate (strokes 
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per minute) (Soper & Hume 2004; 
Metcalfe et al. 2013). 
MATERIALS AND METHODS
STUDY DESIGN
After initial familiarization to the 
testing protocol, the participants 
performed two rowing CPET tests to 
measure VO2 peak. VO2 peak during 
rowing was measured twice to check 
the reproducibility. Predicted VO2 
peak was calculated using the newly 
developed equation, requiring the use 
of Final Stage Stroke Power data from 
the rowing tests. The predicted and 
measured VO2 peak were compared 
to assess the accuracy of the new 
prediction equation for Rowing-Ramp 
Protocol test in predicting VO2 peak.
SUBJECTS
Eleven stroke survivors (males: n=6, age 
= 45+15.7 years, height = 158.9+9.09 
cm, weight = 64.3+12.72 kg; females: 
n=5, age = 44+18.2 years, height =  
162.4+12.54 cm, weight = 69.3+18.17 
kg), at least 3 months post-stroke, 
were recruited from the Rehabilitation 
Clinic, Queen Elizabeth Hospital 
to participate in this study. There 
were 9 patients who suffered from 
hemorrhagic (5 males and 4 females), 
and 2 patients were with ischemic 
stroke (1 male and 1 female). Nine 
patients had strokes on the right side 
(5 males and 4 females) and 2 patients 
on the left (1 male and 1 female). Each 
completed a written informed consent 
form. This study was approved by the 
National Medical Research Register 
and Ethics Committee of Universiti 
Malaysia Sabah. The ethical approval 
of this study was obtained from the 
National Medical Research Register 
with reference no.: NMRR-16-38-
28777(IIR) and Universiti Malaysia 
Sabah Medical Research Ethics 
Committee, with reference no.: UMS/
FPSK6.9/100-6/1/95.
 Medically stable stroke survivors 
were shortlisted in Queen Elizabeth 
Hospital. Before approaching 
eligible patient(s), all the case notes 
of potential stroke patients were 
scrutinized to ensure that they were 
fit for the study. With the consent 
and released by the rehabilitation 
specialist doctors, the patients were 
contacted and appointments were 
made with the patients to seek their 
approval and willingness to participate 
in the rehabilitation program.  Besides, 
patients have to fulfill all the inclusion 
criteria listed below:
1. The patient was able to communicate 
(understand instructions)  
2. Patient possessed unilateral 
hemiparesis (left or right)  
3. Medically stable  
4. Able to walk with or without 
assistance (walking aid or helper)  
5. Able to stand with or without 
assistance (walking aid or helper)  
6. Able to sit with or without assistance 
(walking aid or helper)  
7. Able to transfer from a higher 
position (wheelchair or chair) to lower 
position (rowing seat) with or without 
assistance (helper)  
 Conversely, there were exclusion 
criteria to avoid health deterioration for 
the stroke survivors, as a precautionary 
161
Rowing-Ramp CPET Protocol Med & Health Jun 2019;14(1): 157-171
step, which were patients with 
comorbidities (such as severe heart 
failure, severe hypertension) and 
serious medical condition (such as 
asthma). To ensure all hemiparetic 
stroke patients recruited able to perform 
rowing, patients with elbow flexor 
contracture, plantar flexor contracture, 
unable to bend their knee because 
of hamstring spasticity and unable to 
bend their elbow because of biceps 
spasticity, were also excluded from this 
study. As shown in Figure 1(a), (b), and 
(c), back support, bandage and elastic 
band were used to ensure the correct 
movement of patient that suffer from 
poor hand grip, stiff leg movement, 
and poor sitting balance.
PROCEDURES
 
Stretching sessions were provided 
before the CPET exercise test. The test 
began with a 5-minute warm-up at 
their convenience stroke rate, or when 
HR achieved 100 beats/minute (bpm). 
A 1-minute rest was given before the 
CPET exercise test started. 
 All patients completed two Rowing-
Ramp protocol exercise symptom-
limited tests to determine VO2 peak. 
All exercise tests were performed 
on a Concept II Model C rowing 
ergometer (Morrisville, Vermont, USA), 
on separate days and without normal 
training on the same time of day to 
minimise variation in medication 
effect (Tang et al. 2016) and circadian 
rhythm (Winget et al. 1985). Patients 
were asked to eat a meal and take their 
medications at least 2 hours before 
the test and to avoid caffeine, alcohol, 
and smoking for at least 8 hours before 
the test (to minimise the peak effect of 
beta-blockers). 
Figure 1(a): Pictures showing patients with a 
different physical impairment (a) one hand 
with a poor hand grip was performing rowing 
movement safely.
Figure 1(b): Patient with a hand unable to hold 
the rowing handle and with a stiff leg movement 
was performing rowing movement safely.
Figure 1(c): Patient with a hand unable to hold 
the rowing handle, with a stiff leg movement 
and having difficulties in maintaining sitting 
balance was performing rowing movement 
safely.
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 The rowing protocol and Modified 
Borg Dyspnoea Scale were explained 
to the patients and they were asked to 
perform at their maximal effort. Height 
(cm) and body mass (nearest kg) 
were measured using a stadiometer. 
Resting blood pressure was obtained 
using IA2 Omron Automatic Blood 
Pressure Monitor with IntelliSenseTM 
(Japan). A HR monitor (COSMED K5 
HR monitor, Rome, Italy) was worn 
by patients throughout all the tests. All 
patients underwent a familiarisation 
phase or learning day to learn the 
rowing technique before the test was 
conducted.
 During the Rowing-Ramp exercise 
test protocol, oxygen consumption and 
HR were monitored and continuously 
analysed using a portable open-
circuit spirometer (COSMED Srl-Italy 
K5, Rome, Italy), using the breath-by-
breath method, which was calibrated 
before each test, according to the 
manufacturer’s specifications. Oxygen 
uptake (VO2, STPD), minute ventilation 
(VE, BTPS), carbon dioxide output 
(VCO2, STPD), and HR were recorded 
every second in each stage. The 
data for 30 seconds intervals were 
averaged. The highest values of VO2 
and HR registered within 30 seconds 
during the Rowing-Ramp Protocol test 
were recorded by the metabolic cart 
as VO2max, VO2 peak, Maximal Heart 
Rate (HR max), and peak Heart Rate 
(HR peak). 
 There were no apparent sex-related 
statistical differences in our main 
outcome variables: VO2 peak (Male: 
20.8+11.63 ml/kg/min, Female: 17.8  
+7.65 ml/kg/min, F=0.350, p>0.05), 
VO2 max (Male: 16.3+8.80 ml/kg/
min, Female: 12.0+3.34 ml/kg/min, 
F=1.439, p>0.05), Stroke Power (Male: 
79.3+59.52 W, Female: 30.6+9.04 
W, F=3.231, p>0.05)  and Stroke 
Rate (Male: 35.3+6.89 spm, Female: 
32.8+3.35 spm, F=0.558, p>0.05); thus, 
both male and female patients used 
the same exercise test protocol. Test-
retest reliability data for VO2 peak and 
VO2 max measured 1 week apart.
ROWING-RAMP CPET PROTOCOL 
The Rowing-Ramp protocol is using 
a symptom-limited exercise test. The 
rowing workload used was stroke rate 
(spm) and power output per stroke 
(W). Stroke Rate and Power Output 
were recorded at the end of every 
stage using a Performance Monitor 5 
(PM5). The test comprised stages with 
a 30 seconds duration, and the rowing 
resistance or damper was set at five. 
The starting workload required in the 
first stage is at least 16 spm for 30 
seconds, with workload increment of 
4 spm every 30 seconds until volitional 
exhaustion. 
 The patients were instructed to 
maintain the stroke rate goal as closely 
as possible for the duration of the test. 
We monitored the Stroke Rate at every 
stage to ensure subjects performed 
at the required intensity. The test was 
terminated when patients were no 
longer able to maintain the required 
spm, determined by the required stroke 
being missed on three consecutive 
observations. At the end of the test, the 
observed mean Power Output from 
the PM5 was also recorded. Patients 
were also asked to express their level of 
tiredness using a visual Modified Borg 
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Dyspnoea Scale at the end of the test. 
A cool-down period was performed in 
seconds until HR and blood pressure 
returned to baseline. 
STATISTICAL ANALYSIS
Eleven hemiparetic stroke patients 
completed two Rowing-Ramp protocol 
test for the derivation of the prediction 
equation. The Pearson-Product 
moment correlation coefficient (R) 
was calculated with a chance of 5% 
error, to determine the strength of 
the relationship between measured 
VO2 peak, perceptual measures, and 
rowing performance (stroke power). 
Stepwise linear regression analysis was 
used to generate a prediction equation 
for determining the VO2 peak from 
Modified Borg DS and stroke power. 
To compare the regression lines, the 
differences in slopes and intercepts 
were analysed. 
 The standard error of estimation (SEE) 
and total error (TE) were calculated 
according to the formula below:
       SEE = s.d √(1-r2)
s.d = standard deviation of predicted 
VO2 peak
R = correlation coefficient between 
measured VO2 peak and predicted 
VO2 peak
TE calculated using the formula:  
        TE =  √∑(x-X)2
                  N
where x is the predicted value of the 
VO2 peak. X is the measured value of 
the VO2 peak, and n is the number of 
subjects.
Then, the percentage value of TE (TE%) 
was determined using the following 
formula:
        TE% =TE x100
                             X
 Relationship between measured and 
predicted VO2 peak was evaluated with 
both Pearson correlation coefficient 
and the Bland-Altman statistic, in which 
the differences between the measured 
and predicted VO2 peak from both 
trial 1 and trial 2 were plotted against 
the means of each subject. Difference 
between measured VO2 peak and 
predicted VO2 peak values was also 
analysed using a paired t-test. 
 A test-retest reliability test was 
performed to examine the reliability 
of the Rowing-Ramp protocol as a 
CPET for hemiparetic stroke survivors. 
A paired t-test was also used to 
determine the differences between 
trials (test-retest) for each observed 
variable of HR (HR max, HR peak), 
oxygen consumption (VO2 max, VO2 
peak), perceptual measures (Modified 
Borg Dyspnoea Scale), and rowing 
performance (Mean Stroke Power 
Output). 
 All data were analysed using a 
standard statistical software package 
(SPSS Version 20). The alpha-level was 
set at p<0.05. All data are reported as 
the mean + standard deviation (s.d).
RESULTS
In this study, 11 patients tolerated two 
sessions of the proposed symptom-
limited Rowing-Ramp protocol as a 
CPET specific for stroke population, 
using breath-by-breath method by a 
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portable metabolic cart (COSMED Srl-
Italy K5 Quark B). 
 To determine the reliability of the 
new proposed Rowing-Ramp Protocol 
exercise test, two trials were performed 
by each patient 1 week apart. Maximal 
Modified Borg Dyspnoea Scale 
scores were not significantly different 
between trial 1 and trial 2 (3.6+0.92 
vs. 4.1+1.05; p>0.05). No significant 
difference was found in HR max 
between trial 1 and trial 2 (121.3+39.44 
bpm vs. 138.6+26.11 bpm; p>0.05). 
However, the mean HR peak in trial 
2 (141.2+28.45 bpm) was significantly 
higher than trial 1 (126.3+38.68 bpm; 
p<0.05). Additionally, HR max was 
significantly lower than the HR peak in 
both trials (p<0.05; Table 1).
 In addition to stroke rate, power 
output was also measured in this study 
using the PM5. Rowing performance 
was monitored at every stage to ensure 
that the participant performed at 
the required intensity. There was no 
significant difference in mean values 
for all rowing performance variables 
including the mean stroke power 
output and mean stroke rate, stroke 
rate between trials 1 and 2. Thus, 
Rowing-Ramp protocol produces the 
same mean value of stroke power 
output and stroke rate (Table 1).
 From Table 1, VO2 max was 
significantly lower than the measured 
VO2 peak in both trials (Trial 1: VO2 
max=17.7+9.85 ml/kg/min, VO2 
peak=23.82+13.63 ml/kg/min; Trial 
2: VO2 max=18.26+8.32 ml/kg/min, 
VO2 peak=24.62+11.66 ml/kg/min). 
Variables
Trial 1 
(mean + sd)
Trial 2
(mean + sd)
t-test
T P
HR and Perceptual 
Measures
  MBDS 3.6 + 0.92 4.1 + 1.05 -−1.838 0.10
  HR peak (bpm) 126.3 + 38.68 141.2 + 28.45* -−2.878 0.02
  HR max (bpm) 121.3 + 39.44 138.6 + 26.11 -−2.188 0.05
Oxygen Consumption 
  VO2 max (ml/kg/min) 17.7 +±9.85 18.26 + 8.32 -−0.577 0.576
  VO2 peak (ml/kg/min) 23.82 + 13.63 24.62 + 11.66 -−0.730 0.482
  RER 1.13 + 0.142 1.18 + 0.189 -−1.176 0.267
Perceptual Measures and 
Rowing Performance
SR (spm) 49.0 + 27.54 34.6 + 15.79 - 1.650 0.130
P 25.8 + 2.75 25.8 + 2.89 - 0.000 1.000
* denotes significantly different at p<0.05; df=10; N=11; sd=standard deviation; HR=Heart Rate; 
MBDS=Modified Borg Dyspnoea Scale; HR peak=Peak Heart Rate; HR max=Maximum Heart Rate; 
VO2 max=Maximum Oxygen Consumption; VO2 peak=Peak Oxygen Consumption; RER=Respiratory 
Exchange Ratio; SR=Mean Stroke Rate; P=Mean Stroke Power Output.
Table 1: A test-retest reliability of the Rowing Ramp Protocol as a Cardiopulmonary 
Exercise Test (CPET) for hemiparetic stroke survivor.
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Nonetheless, test-retest reliability data 
for VO2 peak and VO2 max resulted 
in an intra-class correlation of 0.97 
(p<0.01) and 0.95 (p<0.01), respectively 
(Table 1). Therefore, further analysis to 
examine the validity and reliability of 
Rowing-Ramp protocol was performed 
using VO2 peak, since that the CPET 
protocol used in this study is a ramp 
testing protocol.
PREDICTION EQUATION 
RELATIONSHIP BETWEEN VO2 PEAK 
AND ROWING PERFORMANCE 
DURING THE ROWING-RAMP 
PROTOCOL 
To reduce type II error in measuring 
VO2 peak in stroke patients, trial 2 
was used for further analysis in the 
equation development, including 
regression analysis. There was a strong 
and positive correlation between 
relative VO2 peak measured using 
Rowing-Ramp protocol and the mean 
stroke power (R=0.720*, p<0.01); and 
the Final Stage Stroke Power (R=0.859*, 
p<0.01) (Table 2).
 Based on the significant correlation, 
both power output and Final Stage 
Stroke Power were entered into a 
linear regression equation (Table 3). 
Table 3 showed that Final Stage Stroke 
Power has the smallest standard error 
of regression (SE=5.5831). A smaller 
the standard error of R-square denotes 
a shorter distance away from the 
regression line. Final Stage Stroke 
Power also had the highest R-squared 
(73.8%) and adjusted R-squared 
(70.9%), and also has the smallest 
Trials VO2 max 
(ml/kg/min)
VO2 peak 
(ml/kg/min)
Pearson Correlation T-test
R p t p
Trial 1 
(mean + sd)
17.7 ± 9.85 23.82 ± 
13.63*
0.968 <0.01 −4.228 <0.01
Trial 2 
(mean + sd)
18.26 ± 8.32 24.62 ± 
11.66*
0.962 <0.01 −4.887 <0.01
Notes: * denotes significantly different at p<0.05; df=10; N=11; R=Correlation Coefficient; sd=standard 
deviation; VO2 max=Maximum Oxygen Consumption; VO2 peak=Peak Oxygen Consumption.
Table 2: Correlation between Measured Maximum Oxygen Consumption, VO2 max 
and Peak Oxygen Consumption, VO2 peak of each trial
DV Pred F value P SE R2 R2 R2(ADJ) Drop-
off
VIF Durbin- 
Watson
VO2 
peak FSSP 25.326 0.001 5.58310 73.8% 70.9% 2.9% 1.000 3.186
VO2 
peak P 9.708 0.012 7.56262 51.9% 46.5% 5.4% 1.000 1.761
Pred.=Predictor; SE=Standard error; VIF=variance inflation factor; R=correlation coefficient; * denotes 
significantly different at p<0.05; df=10; N=11; VO2 peak=Peak Oxygen Consumption; P=Mean Stroke Power 
Output; FSSP=Final Stage Stroke Power
Table 3. Linear regression analysis for Mean Stroke Power and Final Stage Stroke Power
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drop-off from adjusted R-squared to 
the predicted R-squared (2.9%).
 Table 3 displayed Final Stage Stroke 
Power has a significant and the highest 
F value (F=25.326, p<0.01), and has 
a higher correlation value with VO2 
peak (R=0.859) than power output 
(R=0.720). From the regression analysis 
with a high and significant F value, 
70.9% can predict the VO2 peak using 
the regression equation. Additionally, 
70.9% of the total sum of squares 
can be explained using the estimated 
regression equation to predict the VO2 
peak. The remaining 29.1% is an error.
From the t-distribution table, at p<0.05 
and df=9 (df=N-2), the critical value 
is 2.2622. Thus, when the standard 
error of estimate regression is 5.5831, 
variance or standard deviation for VO2 
peak is as follows:
Standard deviation for VO2 peak 
= 2.2622 x× SE of estimate regression 
= 2.2622 x× 5.58310 
= 12.63
 From linear regression analysis 
(Table 4), the significant coefficient 
and constant value for Final Stage 
Stroke Power related to VO2 peak are 
0.232 (p<0.01) and 11.429 (p<0.01), 
respectively. The Final Stage Stroke 
Power was the single best predictor of 
relative VO2 peak, explaining 70.9% 
of the variation. Therefore, to estimate 
VO2 peak using the indirect method, 
we used the following regression:
VO2 peak (ml/kg/min) = 11.429 + 0.232 
(Final Stage Stroke Power) + 12.63
Beta=0.859, p<0.01
This formula was established using 
the linear regression of the relative 
VO2 peak against the Final Stage 
Stroke Power output, expressed in 
watts, attained exclusively during the 
Rowing-Ramp protocol test. 
MEASURED AND PREDICTED VO2 
PEAK
Measured VO2 peak was significantly 
correlated with predicted VO2 peak in 
both trials, suggesting that measured 
VO2 peak is associated with predicted 
VO2 peak (R1=0.83, p<0.01; R2=0.81, 
p<0.01) (Figure 2). Therefore, VO2 
peak calculated using the established 
predicted equation is acceptable.  
 To ensure a more thorough 
assessment of the relationship between 
the measured and predicted VO2 peak, 
Bland-Altman plots were utilized. 
Differences between the measured 
and predicted VO2 peak are graphed 
against the means of the measured 
Model Unstandardised 
Coefficients
Standardised 
Coefficients T
Sig. 
95%CI for B
B Std. Error Beta Lower Bound
Upper 
Bound
(Constant)
FSSP
11.429
0.232
3.068
0.046
0.859 3.726
5.033
0.005
0.001
4.489
0.128
18.369
0.336
* denotes significantly different at p<0.05; df=10; N=11; FSSP=Final Stage Stroke Power
Table 4. Linear regression analysis for Final Stage Stroke Power 
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and predicted VO2 peak (Figure 3). The 
mean difference or bias in measured 
and predicted VO2 peak was 0.37. Two 
s.d. put the estimated range of mean 
differences as -6.6 to 7.4 ml/kg/min, 
with all but four subjects falling within 
this range or limit of agreement. As 
displayed in Figure 4, both predicted 
VO2 peak (R=0.95, p<0.01) and 
measured VO2 peak (R=0.94, p<0.01) 
at trial 1 correlated significantly with 
trial 2, indicates that predicted VO2 
peak is reproducible.  
DISCUSSION AND 
CONCLUSION
CPET is an integrated and 
comprehensive tool to analyze 
cardiovascular, respiratory, metabolic 
and work indices for both healthy and 
diseased population, that can be used 
to understand the cause of exertion 
intolerance (Stevens et al. 2018). Even, 
Figure 2: Correlation between peak oxygen uptake (VO2 peak) measured during Rowing-Ramp 
protocol test and predicted peak oxygen uptake. Each data point represents an individual subject 
data of measured and predicted VO2 peak. Circles and solid line represent Trial 1. Whereas, diamonds 
and dotted line represent Trial 2. N=11.
Figure 3: Bland-Altman plots of measured and predicted VO2 peak data from trial 1 and trial 2.
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CPET measures including VO2 peak 
provides a foundation to evaluate 
metabolic functional impairment 
(Stevens et al. 2018) especially among 
elderly with high risk for cardiovascular 
disease (Corra et al. 2018).
 Results from this study demonstrate 
newly developed Rowing-Ramp 
protocol with a shorter and smaller 
work increment (4 spm every 30 
seconds), and the new predictive 
equation is valid and reliable to 
estimate VO2 peak of hemiparetic 
stroke patients. This observation is 
substantiated by the absence of a 
significant difference between the 
measured and predicted VO2 peak, as 
well as by a significant and high value 
of test-retest correlation coefficients. 
Hence, there is a high reproducibility 
of measured and predicted VO2 peak 
in hemiparetic stroke patients who 
were examined twice, 7 days apart. 
 This study also further confirms that a 
ramp protocol produces high reliability 
in oxygen uptake on different days, 
as mentioned by Whipp et al. (1981), 
even among stroke patients. Since 
hemiparetic stroke patients are unable 
to achieve maximal aerobic power, 
symptom-limited CPET parameters 
that were derived from submaximal 
tests used in this study is reproducible 
(Corra et al. 2018). 
 Additionally, a ramp protocol is 
more suitable for stroke patients 
because a ramp protocol produces 
lower electromyography amplitude, 
VO2 and HR than a steps protocol in 
a submaximal cycle ergometer test 
(Zuniga et al. 2012; Zuniga et al. 2013). 
A ramp protocol also produces greater 
peak power output (Zuniga et al. 2013) 
and metabolic responses (Zuniga et 
al. 2012) than the step incremental 
cycle ergometer test. Therefore, a 
ramp protocol will facilitate achieving 
a VO2 plateau (Zuniga et al. 2012; 
Zuniga et al. 2013). Similarly, Myers 
and Bellin (2000) proposed that ramp 
protocol should be used within clinical 
populations and untrained subjects. 
Figure 4: Test-retest reliability of measured and predicted peak oxygen uptake. Each data point 
represents an individual subject. Diamonds represent predicted VO2 peak, and circles represent 
measured VO2 peak. N=11.
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Additionally, a previous study used a 
ramped Bruce protocol and found it 
to better record the VO2 max than the 
standardised Bruce protocol (Will & 
Walter 1999). 
 The proposed equation in this study 
had a %SEE of 18.69%, suggesting little 
error associated with the regression 
for the measured compared with the 
predicted VO2 peak. The TE from the 
current study was 20.75% of the mean 
measured VO2 peak, demonstrating 
a strong relationship between the 
measured and predicted values. 
 From the regression equation 
proposed in this study, changes in VO2 
peak can be reflected by changes in 
stroke power output value. This current 
study is in agreement with Shimoda 
and Kawakami (2005), who found that 
maximal oxygen consumption was 
highly and strongly correlated with 
critical power among male university 
rowers (R=0.81), suggesting that 
rowing performance can be evaluated 
through stroke power output, without 
directly measuring maximal oxygen 
consumption as an index of aerobic 
capacity in stroke patients (Shimoda & 
Kawakami 2005). 
 Future studies are required on a 
larger independent sample of stroke 
patients to cross-validate the proposed 
equation. Even, using a different 
group of heart disease patients, with 
other metabolic and neurological 
diseases. This study supports the use 
of this new Rowing-Ramp protocol 
as a CPET, which is a non-invasive 
method to predict relative VO2 peak 
in hemiparetic stroke survivors. This 
would easily provide accessible and 
relevant data that could be incorporated 
into a physical fitness rehabilitation 
programme. Because people with 
symptoms, chronic conditions, or 
disabilities may have limited exercise 
tolerance and are at increased risk for 
adverse events associated with physical 
activity, they require clinical exercise 
evaluation to screen for potentially 
dangerous signs or symptoms of 
exercise intolerance and to establish 
safer and more appropriate parameters 
for their exercise prescription (Stevens 
et al. 2018, Corrà et al. 2018). 
 This study was limited only to stroke 
patients that could at least walk and 
sit with or without assistance. This 
is due to the application of rowing 
ergometer that might need them to 
sit without support on the rowing 
machine. Without a good sitting 
balance, a patient might fall off the 
rowing ergometer. Added to this, the 
rowing ergometer is low in height 
compared to treadmill and cycling 
ergometer. Stroke patient might need 
some assistance to move to its seat as 
rowing’s seat is movable (not static).
 In this study, the safety of patients 
was the priority specifically while 
transferring or assisting them onto the 
rowing ergometer. Though there is 
a foot-placement pads on a rowing 
machine, patients might not be able to 
attach their own feet on that position 
as either side of their body is weak due 
to hemiparesis. In addition, the handles 
are attached quite a distance from the 
patient’s position. For patients with stiff 
(spastic) distal, the affected side could 
be secured to the handles so that they 
could row easily. Equipment used in 
this study was the portable metabolic 
cart K5 (Cosmed) which might be 
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uncomfortable for these patients during 
the test. Throughout rowing training, a 
few of the stroke patients were having 
episodes of seizure thus affecting their 
performance in RRP test. Medications 
were taken to reduce and control the 
attack was another factor.
 The results of this study show that 
the new Rowing-Ramp protocol is 
feasible as a CPET for stroke patients 
because it is safer for people with 
physical impairments. Additionally, 
the Rowing-Ramp protocol test offers 
a viable alternative exercise test for 
risk stratification, as well as to monitor 
physiological status in stroke patients 
who have chronic heart disease and 
physical disability. In which,  would 
allow a physical therapist, a physical 
fitness therapist, or a clinical exercise 
physiologist to estimate peak oxygen 
consumption to be used as an exercise 
intensity for individualised training 
programmes and to track changes in 
cardiopulmonary fitness performance 
in a timely manner. This would also 
eliminate the need for expensive 
metabolic equipment or trained 
personnel associated with laboratory 
testing.
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